Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37)

Diabetes Care

Volumn 22, Issue 7, 1999, Pages 1125-1136

  Mehta, Ziyah ^a   Cull, Carole ^a   Stratton, Irene ^a   Yudkin, John ^b   Jenkinson, Crispin ^c   Fletcher, Astrid ^d   Battersby, Clare ^e   Holman, Rury ^a   Turner, Robert ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORPROPAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; INSULIN; METFORMIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIABETIC ANGIOPATHY; FEMALE; HEALTH; HUMAN; HYPERTENSION; HYPOGLYCEMIA; JOB SATISFACTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MOOD; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TENSION;

AFFECT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BLOOD PRESSURE; COGNITION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS; HUMANS; JOB SATISFACTION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; UNITED STATES;

EID: 0033015915     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.7.1125     Document Type: Article

References (31)

1. Garcia MJ, McNamara PM, Gordon T, Kannell WB: Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 23: 105-111, 1974
2. UKPDS Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
3. U.K. Prospective Diabetes Study Group: U.K. Prospective Diabetes Study 16: Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44:1249-1258, 1995
4. Mayou R, Bryant B, Turner R: Quality of life in non-insulin-dependent diabetes and a comparison with insulin-dependent diabetes. J Psychosom Res 34:1-11, 1990
5. UKPDS Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703-713, 1998
6. Testa MA, Anderson RB, Nackley JF, Hollenberg NK: Quality of life and antihypertensive therapy in men: a comparison of captopril with enalapril. N Engl J Med 328:907-913, 1993
7. Testa MA, Hollenberg NK, Anderson RB, Williams GH: Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. Am J Hypertens 4:363-373, 1991
8. UKPDS Group: UK Prospective Diabetes Study VIII: Study design, progress and performance. Diabetologia 34:877-890, 1991
9. House JS: Work Stress and Social Support. Reading, MA, Addison-Wesley, 1981
10. McNair DM, Lorr M, Droppleman LF: EdlTS Manual: Profile of Mood States. San Diego, Educational and Industrial Testing Service, 1981
11. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR: The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 21:1-16, 1982
12. Bulpitt CJ, Palmer AJ, Battersby C, Fletcher AE: Association of symptoms of type 2 diabetic patients with severity of disease, obesity, and blood pressure. Diabetes Care 21:111-115, 1998
13. EuroQol Group: EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 16:199-208, 1990
14. Box GEP, Cox DR: An analysis of transformations. J R Stat Soc B 26:211-252, 1964
15. SAS Institute: Statistical Analysis System. 6th ed. Cary, NC, SAS Institute, 1990
16. BMDP Statistical Software: BMDP Statistical Software. Los Angeles, CA, BMDP Statistical Software Inc., 1990
17. UKPDS Group: UKPDS 26: Sulphonylurea failure in non-insulin dependent diabetic patients over 6 years. Diabet Med 15: 297-303, 1998
18. DCCT Research Group: Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care 19:195-203, 1996
19. Johnson JA, Nowatzki TE, Coons SJ: Health-related quality of life of diabetic Pima Indians. Medical Care 34:97-102, 1996
20. Weinberger M, Kirkman MS, Samsa GP, Shortliffe EA, Landsman PB, Cowper PA, Simel DL, Feussner JR: A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycaemic control and health-related quality of life. J Gen Intern Med 10:59-66, 1995
21. Weinberger M, Kirkman MS, Samsa GP, Cowper PA, Shortliffe EA, Simel DL, Feussner JR: The relationship between glycaemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Medical Care 32:1173-1181, 1994
22. Klein BEK, Klein R, Moss SE: Self-rated health and diabetes of long duration: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 21:236-240, 1998
23. Van der Does FEE, De Neeling JND, Snoek FJ, Kostense PJ, Grootenhuis PA, Bouter LM, Heine RJ: Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care 19:204-210, 1996
24. Testa MA, Simonson DC: Health economic benefits and quality of life during improved glycaemic control in patients with Type 2 diabetes mellitus. JAMA 280:1490-1496, 1998
25. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L: Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 20:562-567, 1997
26. Jacobson AM, de Groot M, Samson JA: The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 17:267-274, 1994
27. Hunt LM, Valenzuela MA, Pugh JA: NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care 20:292-298, 1997
28. Keinänen-Kiukaanniemi S, Ohinmaa A, Pajunpää H, Koivukangas P: Health related quality of life in diabetic patients measured by the Nottingham Health Profile. Diabet Med 13:382-388, 1996
29. Peet M: The treatment of anxiety with beta-blocking drugs. Postgrad Med J 64:45-49, 1988
30. Peyrot M, Rubin RR: Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 20: 585-590, 1997
31. Rose M, Burkert U, Scholler G, Schirop T, Danzer G, Klapp BF: Determinants of the quality of life of patients with diabetes under intensified insulin therapy. Diabetes Care 21:1876-1885, 1998